NCT02551718 2022-06-30
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
University of Washington
Phase NA Completed
University of Washington
Fox Chase Cancer Center
University of Washington
Virginia Commonwealth University
Vanderbilt-Ingram Cancer Center
University of California, San Francisco
Mayo Clinic